Priority Date: 21.08.12 (US 201261691454P)

HAPTENS OF OLANZIPINE

  • Application ID: EP13753774
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC combination A61, C07, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd, Mewburn Ellis LLP and 56 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 21.08.2012 - Priority Date (US 201261691454P)
  • 27.02.2014 - Publication A1 (WO2014031587)
  • 01.07.2015 - Publication A1 (EP2888269)